Become a member of the iCMLf – help shape our future

The mission of the iCMLf is to improve outcomes for people with CML globally. Established in 2009 by a leading group of hematologists, the aims of the iCMLf are to foster and coordinate global clinical and research collaborations and to improve CML clinical practice and disease monitoring worldwide. Become a member now!

“The improved survival in CML directly attributable to the use of tyrosine kinase inhibitors is so dramatic that these new agents must be made available to the greatest possible number of eligible patients as rapidly as possible throughout the whole world” - John Goldman iCMLf Chairman

There are numerous activities that come within the iCMLf’s broad charter but the initial focus of the Foundation is to address the needs in CML that are not already being met by other groups, particularly those needs that are best met by a global organisation. Even for this disease area with effective treatment, so much still needs to be tackled to make sure that all patients around the world receive the best possible therapy and care.

Now in its third year the iCMLf has already achieved a great deal:

• Over 40 practicing hematologists (preceptors) have attended educational programs at internationally renowned CML centres of excellence
• Through the iCMLf Virtual Education Program the iCMLf has provided in excess of 5500 people access to up to date online CML education sessions from leading experts
• The ERSAP Diagnosis and Testing Program is providing unprecedented access to CML diagnostics allowing access to treatment along with enhanced monitoring ensuring optimal outcomes for people with CML. The impact of this program has the potential to be dramatic for the people reached along with their community’s.

These iCMLf programs are revolutionising the way CML is managed in the countries we are helping. 

We invite you to join us!

Now is your opportunity to contribute to the work of the iCMLf by becoming a member. Members of the iCMLf will:

• Become part of an international network focused on improving outcomes in CML
• Contribute to the global research and educational programs of the iCMLf
• Access a network of international contacts, including leading hematologists and scientists, with a common interest in CML
• Be invited to attend the iCMLf’s regional meetings
• Nominate candidates for the annual iCMLf Rowley prize
• Nominate candidates for the iCMLf Scientific Advisory Committee and National Representative Board
• Have the opportunity to contribute as a reviewer to the scientific publications of the iCMLf
• Submit articles for the iCMLf twice yearly newsletter
• Receive regular updates on the programs and activities of the iCMLf
• Receive the iCMLf Newsletter and annual report

Membership of the iCMLf is US$100 annually.

A lesser amount can be contributed if full payment is difficult at this time

(minimum $10)

>>> Become a member now! Fill out our membership form here! <<<

Through the work of the iCMLf your support will further the progress towards best possible management for CML patients where ever they reside.